MedPath
HSA Approval

SKIIP NICOTINE MINI LOZENGE 4 MG (MINT)

SIN16971P

SKIIP NICOTINE MINI LOZENGE 4 MG (MINT)

SKIIP NICOTINE MINI LOZENGE 4 MG (MINT)

March 13, 2024

RUBICON RESEARCH PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantRUBICON RESEARCH PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification

Formulation Information

LOZENGE

ORAL

Medical Information

N07BA01

nicotine

Manufacturer Information

RUBICON RESEARCH PRIVATE LIMITED

Rubicon Research Private Limited

Active Ingredients

Nicotine Polacrilex eqv to Nicotine

4.00 mg

Nicotine

Documents

Patient Information Leaflets

Skiip Nicotine Mini Lozenge 4mg Mint PIL.pdf

Approved: March 13, 2024

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

SKIIP NICOTINE MINI LOZENGE 4 MG (MINT) - HSA Approval | MedPath